Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development.
Publication
, Journal Article
Becker, RC
Published in: Journal of thrombosis and thrombolysis
April 2007
Duke Scholars
Published In
Journal of thrombosis and thrombolysis
DOI
EISSN
1573-742X
ISSN
0929-5305
Publication Date
April 2007
Volume
23
Issue
2
Start / End Page
159 / 161
Related Subject Headings
- Stents
- Stem Cells
- Quinolines
- Infusion Pumps, Implantable
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Fibrinolytic Agents
- Endothelial Cells
- Drug-Related Side Effects and Adverse Reactions
- Drug Therapy
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (2007). Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. Journal of Thrombosis and Thrombolysis, 23(2), 159–161. https://doi.org/10.1007/s11239-006-0007-3
Becker, Richard C. “Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development.” Journal of Thrombosis and Thrombolysis 23, no. 2 (April 2007): 159–61. https://doi.org/10.1007/s11239-006-0007-3.
Becker RC. Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. Journal of thrombosis and thrombolysis. 2007 Apr;23(2):159–61.
Becker, Richard C. “Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development.” Journal of Thrombosis and Thrombolysis, vol. 23, no. 2, Apr. 2007, pp. 159–61. Epmc, doi:10.1007/s11239-006-0007-3.
Becker RC. Off-target properties of pharmacotherapy and the importance of mechanistic investigations in early clinical phase drug development. Journal of thrombosis and thrombolysis. 2007 Apr;23(2):159–161.
Published In
Journal of thrombosis and thrombolysis
DOI
EISSN
1573-742X
ISSN
0929-5305
Publication Date
April 2007
Volume
23
Issue
2
Start / End Page
159 / 161
Related Subject Headings
- Stents
- Stem Cells
- Quinolines
- Infusion Pumps, Implantable
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Fibrinolytic Agents
- Endothelial Cells
- Drug-Related Side Effects and Adverse Reactions
- Drug Therapy